|Day Low/High||204.59 / 209.29|
|52 Wk Low/High||150.37 / 228.91|
Altria takes a 45% stake in Cronos and lifts the rest of the pot sector in the process.
The CEO of New Age Beverage Co. describes why the company decided to get into CBD-infused beverages.
Turns to the upside and downside can be subtle but it looks like Constellation Brands is giving us some subtle bullish clues.
New Age Beverages is buying Morinda Holdings, in another deal aimed at growing market share in cannabis-infused products.
Jim Cramer looks for stocks that have potential, especially if trade and tariff woes out of the G-20 meeting stir up volatility.
Here are 4 stocks that can be bought into the stock cyclone that might occur if things don't go the bulls way in the Argentine.
Bruce Linton, CEO of Canopy, said the cannabis industry is likely to continue to cause a commotion across industries in years to come.
Jim Cramer says most - but not all - stocks are in a bear market. He talks about what's happening with Clorox, Coca-Cola, Verizon, Apple and more.
Canopy Growth's fiscal second-quarter revenue misses analysts' estimates.
Citron's Andrew Left has maintained a short position throughout that would appear dangerous to most, yet he seems very confident.
TheStreet founder and Action Alerts Plus portfolio manager Jim Cramer breaks down Tuesday's market action.
Perhaps the highest profile impact on Tilray equity performance has been the interest of Andrew Left of Citron Research.
Tilray will have a lot to tackle this evening.
Cramer said the recent selloff has been good for investors because it reset expectations. Here's what he thinks about energy and the Fed.
Jim Cramer takes a closer look at Emerson Electric, Arista Networks, Foot Locker, SailPoint Technologies, Crown Holdings, Idexx Laboratories and more.
We are placing Five Below and Constellation Brands in the Bullpen as we hunt for more stocks levered to the consumer.
Consumer Discretionary stocks were the hottest on Wednesday, though all eleven sectors easily finished in the green.
Coca-Cola CEO James Quincey says the company has no plans to develop drinks or any other products infused with CBD, the non-psychoactive ingredient in marijuana.
Tinley's CEO talks about its cannabis-infused beverages.
Rapid growth in cannabis industry is fueling new competition
This is serious: The market is ignoring legitimate, positive earnings, says Jim Cramer, and tariffs and rates are the culprits.
Panic is not an investment strategy, says Jim Cramer. But when everyone else is panicking, that's when you need to buy.
Jim Cramer talked legal weed with Bill Newlands of Constellation Brands and Bruce Linton of Canopy Growth.
Jim Cramer looks ahead to the fourth quarter and has your game plan for next week.
Jim Cramer lists the things we need to see before the bear backs off and the market regains its footing.
Jim Cramer weighs in on Anheuser-Busch InBev, Alteryx, Walker & Dunlop, Kratos Defense & Security, Johnson Controls, Nektar Therapeutics, Align Technology.
Jim Cramer is concerned about risk, and the Fed. But, he says, you need to get in there and talk with the CEOs to get the real story about the economy.
Jim Cramer, celebrating the opening of the NFL season, says this is just another day of total tech mayhem.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.